Cargando…
The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12–15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a stand...
Autores principales: | Atif, Fahim, Patel, Neil R., Yousuf, Seema, Stein, Donald G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482510/ https://www.ncbi.nlm.nih.gov/pubmed/26110872 http://dx.doi.org/10.1371/journal.pone.0131441 |
Ejemplares similares
-
Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
por: Atif, Fahim, et al.
Publicado: (2019) -
Progesterone Attenuates Stress-Induced NLRP3 Inflammasome Activation and Enhances Autophagy Following Ischemic Brain Injury
por: Espinosa-Garcia, Claudia, et al.
Publicado: (2020) -
Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide
por: Giannakopoulou, Maria, et al.
Publicado: (2022) -
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020) -
Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma
por: Das, Arabinda, et al.
Publicado: (2015)